Inflammatory bowel disease position statement of the Italian Society of Colorectal Surgery (SICCR): Crohn’s disease
2020-01-01 Pellino, G.; Keller, D. S.; Sampietro, G. M.; Angriman, I.; Carvello, M.; Celentano, V.; Colombo, F.; Di Candido, F.; Laureti, S.; Luglio, G.; Poggioli, G.; Rottoli, M.; Scaringi, S.; Sciaudone, G.; Sica, G.; Sofo, L.; Leone, S.; Danese, S.; Spinelli, A.; Delaini, G.; Selvaggi, F.
Development and validation of the Nancy histological index for UC
2017-01-01 Marchal-Bressenot, A; Salleron, J; Boulagnon-Rombi, C; Bastien, C; Cahn, V; Cadiot, G; Diebold, Md; Danese, S; Reinisch, W; Schreiber, S; Travis, S; Peyrin-Biroulet, L
Thrombotic complications in inflammatory bowel disease: A multifactorial etiology
2001-01-01 Papa, A; De Stefano, V; Danese, S; Gasbarrini, A; Gasbarrini, G
First-line therapy in adult Crohn's disease: who should receive anti-TNF agents?
2013-01-01 Peyrin-Biroulet, L; Fiorino, G; Buisson, A; Danese, S
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 3: Special situations (Spanish version)
2015-01-01 van Assche, G; Dignass, A; Bokemeyer, B; Danese, S; Gionchetti, P; Moser, G; Beaugerie, L; Gomolion, F; Hauser, W; Herrlinger, K; Oldenburg, B; Panes, J; Portela, F; Rogier, G; Stein, J; Tilg, H; Travis, S; Lindsay, Jo
Oral Iron for IBD Patients: Lessons Learned at Time of COVID-19 Pandemic
2020-01-01 D’Amico, Ferdinando; Peyrin-Biroulet, Laurent; Danese, Silvio
Vedolizumab and etrolizumab for ulcerative colitis: twins or simple cousins?
2020-01-01 D'Amico, Ferdinando; Danese, Silvio; Peyrin-Biroulet, Laurent
Early Diagnosis and Treatment of Postoperative Endoscopic Recurrence of Crohn's Disease: Partial Benefit by Infliximab-A Pilot Study
2012-01-01 Sorrentino, D; Terrosu, G; Paviotti, A; Geraci, M; Avellini, C; Zoli, G; Fries, W; Danese, S; Occhipinti, P; Croatto, T; Zarifi, D
Defining Disease Severity in Inflammatory Bowel Diseases: Current and Future Directions
2016-01-01 Peyrin-Biroulet, L; Panes, J; Sandborn, Wj; Vermeire, S; Danese, S; Feagan, Bg; Colombel, Jf; Hanauer, Sb; Rycroft, B
Anti TNF-alpha Treatment For Crohn's Disease: "Menage A Trois"
2010-01-01 Danese, S
Biological agents for ulcerative colitis : Hypes and hopes
2008-01-01 Danese, S.; Angelucci, E.; Malesci, A.; Caprilli, R.
The Crohn's Disease-Ulcerative Colitis Clinical Appraisal
2016-01-01 D'Haens, G; Bressler, B; Danese, S; Gibson, P; Hanauer, Sb; Sandborn, W
Interleukin-23 Blockers: Born to be First-line Biologic Agents in Inflammatory Bowel Disease?
2019-01-01 Argollo, Mc; Allocca, M; Furfaro, F; Peyrin-Biroulet, L; Danese, S
Efficacy of TNF Antagonists Beyond One Year in Adult and Pediatric Inflammatory Bowel Diseases: A Systematic Review
2010-01-01 Oussalah, A; Danese, S; Peyrin-Biroulet, L
Medical Challanges in Inflammatory Bowel Disease: Quo Vadis in Disease Complexity?
2014-01-01 Danese, S; Peyrin-Biroulet, L
Diffusion-weighted MRI in inflammatory bowel disease
2018-01-01 Pouillon, L; Laurent, V; Pouillon, M; Bossuyt, P; Bonifacio, C; Danese, S; Deepak, P; Loftus, Ev; Bruining, Dh; Peyrin-Biroulet, L
Inflammation and the mucosal microcirculation in inflammatory bowel disease: the ebb and flow
2007-01-01 Danese, S
Ulcerative Colitis
2011-01-01 Danese, S; Fiocchi, C
Integrated models of care in managing inflammatory bowel disease: a discussion
2012-01-01 Mikocka-Walus, Aa; Andrews, Jm; Bernstein, Cn; Graff, La; Walker, Jr; Spinelli, A; Danese, S; Van Der Woude, Cj; Goodhand, J; Rampton, D; Moser, G.
Inflammatory bowel disease position statement of the Italian Society of Colorectal Surgery (SICCR): ulcerative colitis
2020-01-01 Pellino, G; Keller, D S; Sampietro, G M; Carvello, M; Celentano, V; Coco, C; Colombo, F; Geccherle, A; Luglio, G; Rottoli, M; Scarpa, M; Sciaudone, G; Sica, G; Sofo, L; Zinicola, R; Leone, S; Danese, S; Spinelli, A; Delaini, G; Selvaggi, F
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Inflammatory bowel disease position statement of the Italian Society of Colorectal Surgery (SICCR): Crohn’s disease | 1-gen-2020 | Pellino, G.; Keller, D. S.; Sampietro, G. M.; Angriman, I.; Carvello, M.; Celentano, V.; Colombo, F.; Di Candido, F.; Laureti, S.; Luglio, G.; Poggioli, G.; Rottoli, M.; Scaringi, S.; Sciaudone, G.; Sica, G.; Sofo, L.; Leone, S.; Danese, S.; Spinelli, A.; Delaini, G.; Selvaggi, F. | |
| Development and validation of the Nancy histological index for UC | 1-gen-2017 | Marchal-Bressenot, A; Salleron, J; Boulagnon-Rombi, C; Bastien, C; Cahn, V; Cadiot, G; Diebold, Md; Danese, S; Reinisch, W; Schreiber, S; Travis, S; Peyrin-Biroulet, L | |
| Thrombotic complications in inflammatory bowel disease: A multifactorial etiology | 1-gen-2001 | Papa, A; De Stefano, V; Danese, S; Gasbarrini, A; Gasbarrini, G | |
| First-line therapy in adult Crohn's disease: who should receive anti-TNF agents? | 1-gen-2013 | Peyrin-Biroulet, L; Fiorino, G; Buisson, A; Danese, S | |
| Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 3: Special situations (Spanish version) | 1-gen-2015 | van Assche, G; Dignass, A; Bokemeyer, B; Danese, S; Gionchetti, P; Moser, G; Beaugerie, L; Gomolion, F; Hauser, W; Herrlinger, K; Oldenburg, B; Panes, J; Portela, F; Rogier, G; Stein, J; Tilg, H; Travis, S; Lindsay, Jo | |
| Oral Iron for IBD Patients: Lessons Learned at Time of COVID-19 Pandemic | 1-gen-2020 | D’Amico, Ferdinando; Peyrin-Biroulet, Laurent; Danese, Silvio | |
| Vedolizumab and etrolizumab for ulcerative colitis: twins or simple cousins? | 1-gen-2020 | D'Amico, Ferdinando; Danese, Silvio; Peyrin-Biroulet, Laurent | |
| Early Diagnosis and Treatment of Postoperative Endoscopic Recurrence of Crohn's Disease: Partial Benefit by Infliximab-A Pilot Study | 1-gen-2012 | Sorrentino, D; Terrosu, G; Paviotti, A; Geraci, M; Avellini, C; Zoli, G; Fries, W; Danese, S; Occhipinti, P; Croatto, T; Zarifi, D | |
| Defining Disease Severity in Inflammatory Bowel Diseases: Current and Future Directions | 1-gen-2016 | Peyrin-Biroulet, L; Panes, J; Sandborn, Wj; Vermeire, S; Danese, S; Feagan, Bg; Colombel, Jf; Hanauer, Sb; Rycroft, B | |
| Anti TNF-alpha Treatment For Crohn's Disease: "Menage A Trois" | 1-gen-2010 | Danese, S | |
| Biological agents for ulcerative colitis : Hypes and hopes | 1-gen-2008 | Danese, S.; Angelucci, E.; Malesci, A.; Caprilli, R. | |
| The Crohn's Disease-Ulcerative Colitis Clinical Appraisal | 1-gen-2016 | D'Haens, G; Bressler, B; Danese, S; Gibson, P; Hanauer, Sb; Sandborn, W | |
| Interleukin-23 Blockers: Born to be First-line Biologic Agents in Inflammatory Bowel Disease? | 1-gen-2019 | Argollo, Mc; Allocca, M; Furfaro, F; Peyrin-Biroulet, L; Danese, S | |
| Efficacy of TNF Antagonists Beyond One Year in Adult and Pediatric Inflammatory Bowel Diseases: A Systematic Review | 1-gen-2010 | Oussalah, A; Danese, S; Peyrin-Biroulet, L | |
| Medical Challanges in Inflammatory Bowel Disease: Quo Vadis in Disease Complexity? | 1-gen-2014 | Danese, S; Peyrin-Biroulet, L | |
| Diffusion-weighted MRI in inflammatory bowel disease | 1-gen-2018 | Pouillon, L; Laurent, V; Pouillon, M; Bossuyt, P; Bonifacio, C; Danese, S; Deepak, P; Loftus, Ev; Bruining, Dh; Peyrin-Biroulet, L | |
| Inflammation and the mucosal microcirculation in inflammatory bowel disease: the ebb and flow | 1-gen-2007 | Danese, S | |
| Ulcerative Colitis | 1-gen-2011 | Danese, S; Fiocchi, C | |
| Integrated models of care in managing inflammatory bowel disease: a discussion | 1-gen-2012 | Mikocka-Walus, Aa; Andrews, Jm; Bernstein, Cn; Graff, La; Walker, Jr; Spinelli, A; Danese, S; Van Der Woude, Cj; Goodhand, J; Rampton, D; Moser, G. | |
| Inflammatory bowel disease position statement of the Italian Society of Colorectal Surgery (SICCR): ulcerative colitis | 1-gen-2020 | Pellino, G; Keller, D S; Sampietro, G M; Carvello, M; Celentano, V; Coco, C; Colombo, F; Geccherle, A; Luglio, G; Rottoli, M; Scarpa, M; Sciaudone, G; Sica, G; Sofo, L; Zinicola, R; Leone, S; Danese, S; Spinelli, A; Delaini, G; Selvaggi, F |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista40134
Data di pubblicazione
- In corso di stampa9
- 2020 - 202712186
- 2010 - 201915980
- 2000 - 20097460
- 1990 - 19993486
- 1980 - 1989935
- 1970 - 197977
- 1959 - 19591
Editore
- Elsevier Inc.823
- Elsevier B.V.809
- Springer Science and Business Med...552
- John Wiley and Sons Inc549
- Oxford University Press506
- Lippincott Williams and Wilkins435
- Springer374
- Elsevier Ltd350
- MDPI348
- Springer Nature296
Rivista
- EUROPEAN UROLOGY535
- BLOOD372
- PLOS ONE313
- JOURNAL OF NEUROLOGY291
- EUROPEAN JOURNAL OF HEART FAILURE281
- NEUROLOGY270
- DIGESTIVE AND LIVER DISEASE245
- EUROPEAN HEART JOURNAL225
- MULTIPLE SCLEROSIS219
- SCIENTIFIC REPORTS215
Keyword
- Humans3553
- Male2080
- Female1864
- Middle Aged1472
- Aged1290
- Adult1100
- COVID-19636
- Retrospective Studies628
- Treatment Outcome603
- Prognosis483
Lingua
- eng29490
- ita1971
- fre65
- und55
- spa34
- ger26
- por12
- enm6
- rus6
- grc3
Accesso al fulltext
- no fulltext32003
- reserved4297
- open3722
- partially open104
- embargoed7
- mixed1